Quanterix Corporation (QTRX): Price and Financial Metrics
Quanterix Corporation (QTRX)
Today's Latest Price: $27.50 USD
Updated Jul 9 4:00pm
Add QTRX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 58 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
QTRX Stock Summary
- QTRX's went public 2.59 years ago, making it older than merely 7.68% of listed US stocks we're tracking.
- QTRX's price/sales ratio is 12.67; that's higher than the P/S ratio of 89.45% of US stocks.
- With a year-over-year growth in debt of 296.87%, Quanterix Corp's debt growth rate surpasses 94.66% of about US stocks.
- Stocks that are quantitatively similar to QTRX, based on their financial statements, market capitalization, and price volatility, are ECOR, IGC, LC, FLDM, and TUFN.
- Visit QTRX's SEC page to see the company's official filings. To visit the company's web site, go to www.quanterix.com.
QTRX Stock Price Chart Technical Analysis Charts
QTRX Price/Volume Stats
| Current price | $27.50 | 52-week high | $33.67 |
| Prev. close | $26.91 | 52-week low | $10.90 |
| Day low | $26.51 | Volume | 115,338 |
| Day high | $27.92 | Avg. volume | 166,958 |
| 50-day MA | $26.51 | Dividend yield | N/A |
| 200-day MA | $23.73 | Market Cap | 778.55M |
Quanterix Corporation (QTRX) Company Bio
Quanterix Corporation develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and Asia Pacific. It develops Simoa HD-1 Analyzer, a sensitive protein detection platform, which analyzes approximately six biomarkers per test; and SR-X system that supports the detection capability of approximately six biomarkers per test. The company’s products also comprise kits, such as beads, capture and detector reagents, enzyme reagents, and enzyme substrates to run tests; and consumables, such as proprietary Simoa disks, cuvettes, and disposable tips. In addition, it offers contract research services, including sample testing, assay development, and custom development services. Quanterix Corporation primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was founded in 2007 and is based in Lexington, Massachusetts.
Loading social stream, please wait...